SCYNEXIS Stock Forecast, Price & News

SCYNEXIS (NASDAQ:SCYX) Frequently Asked Questions

Is SCYNEXIS a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for SCYNEXIS in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SCYNEXIS stock.
View analyst ratings for SCYNEXIS or view top-rated stocks.

How has SCYNEXIS's stock price been impacted by Coronavirus (COVID-19)?

SCYNEXIS's stock was trading at $7.8020 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SCYX stock has decreased by 39.1% and is now trading at $4.75.
View which stocks have been most impacted by COVID-19.

When is SCYNEXIS's next earnings date?

SCYNEXIS is scheduled to release its next quarterly earnings announcement on Monday, April 4th 2022.
View our earnings forecast for SCYNEXIS.

How were SCYNEXIS's earnings last quarter?

SCYNEXIS, Inc. (NASDAQ:SCYX) posted its quarterly earnings results on Wednesday, November, 10th. The company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.79) by $0.73. The firm earned $0.52 million during the quarter, compared to the consensus estimate of $0.50 million. During the same period last year, the firm earned ($0.28) EPS.
View SCYNEXIS's earnings history.

When did SCYNEXIS's stock split? How did SCYNEXIS's stock split work?

SCYNEXIS shares reverse split on Friday, July 17th 2020. The 1-10 reverse split was announced on Thursday, July 16th 2020. The number of shares owned by shareholders was adjusted after the market closes on Thursday, July 16th 2020. An investor that had 100 shares of SCYNEXIS stock prior to the reverse split would have 10 shares after the split.

What price target have analysts set for SCYX?

4 equities research analysts have issued 12-month price targets for SCYNEXIS's shares. Their forecasts range from $20.00 to $35.00. On average, they expect SCYNEXIS's stock price to reach $25.67 in the next year. This suggests a possible upside of 440.4% from the stock's current price.
View analysts' price targets for SCYNEXIS or view top-rated stocks among Wall Street analysts.

Who are SCYNEXIS's key executives?

SCYNEXIS's management team includes the following people:

• Marco Taglietti, President, Chief Executive Officer & Director
• Lawrence R. Hoffman, Chief Financial Officer
• David Angulo Gonzalez, Chief Medical Officer
• Rajeshwar Motheram, SVP-Pharmaceutical Development & Supply Chain
• Nkechi Azie, VP-Clinical Development & Medical Affairs

Who are some of SCYNEXIS's key competitors?

Some companies that are related to SCYNEXIS include Prelude Therapeutics (PRLD), VBI Vaccines (VBIV), BELLUS Health (BLU), Basilea Pharmaceutica (BPMUF), LumiraDx (LMDX), ORIC Pharmaceuticals (ORIC), OrganiGram (OGI), Ocular Therapeutix (OCUL), Adicet Bio (ACET), Dyne Therapeutics (DYN), Rigel Pharmaceuticals (RIGL), Pliant Therapeutics (PLRX), Vera Therapeutics (VERA), Affimed (AFMD) and Veru (VERU).
View all of SCYX's competitors.

What other stocks do shareholders of SCYNEXIS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SCYNEXIS investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Sorrento Therapeutics (SRNE), Gran Tierra Energy (GTE), KushCo (KSHB), Zosano Pharma (ZSAN), Bionano Genomics (BNGO), Outlook Therapeutics (OTLK), Cogent Biosciences (UMRX) and Aeterna Zentaris (AEZS).

What is SCYNEXIS's stock symbol?

SCYNEXIS trades on the NASDAQ under the ticker symbol "SCYX."

How do I buy shares of SCYNEXIS?

Shares of SCYX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is SCYNEXIS's stock price today?

One share of SCYX stock can currently be purchased for approximately $4.75.

How much money does SCYNEXIS make?

SCYNEXIS has a market capitalization of $113.76 million and generates $120 thousand in revenue each year. The company earns $-55.19 million in net income (profit) each year or ($4.43) on an earnings per share basis.

How many employees does SCYNEXIS have?

SCYNEXIS employs 38 workers across the globe.

What is SCYNEXIS's official website?

The official website for SCYNEXIS is www.scynexis.com.

Where are SCYNEXIS's headquarters?

SCYNEXIS is headquartered at 1 EVERTRUST PLAZA 13TH FLOOR, JERSEY CITY NJ, 07302.

How can I contact SCYNEXIS?

SCYNEXIS's mailing address is 1 EVERTRUST PLAZA 13TH FLOOR, JERSEY CITY NJ, 07302. The company can be reached via phone at (201) 884-5485, via email at [email protected], or via fax at 201-884-5490.